Celine Cougoule
Toulouse, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Sibiriline, a novel dual inhibitor of necroptosis and ferroptosis, prevents RIPK1 kinase activity and (phospho)lipid peroxidation as a potential therapeutic strategy.
Journal: Cell death discovery
Published: September 18, 2025
Curcumin-mediated NRF2 induction limits inflammatory damage in, preclinical models of cystic fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 21, 2024
Lung organoids as a human system for Mycobacteria infection modeling and drug testing.
Journal: The FEBS journal
Published: November 08, 2024
Surface-anchored carbon nanomaterials for antimicrobial surfaces.
Journal: Nanoscale
Published: August 22, 2024
Portimine A toxin causes skin inflammation through ZAKα-dependent NLRP1 inflammasome activation.
Journal: EMBO molecular medicine
Published: July 31, 2024
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 Variants.
Journal: Viruses
Published: February 15, 2024
Medications Modulating the Acid Sphingomyelinase/Ceramide System and 28-Day Mortality among Patients with SARS-CoV-2: An Observational Study.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 26, 2023
EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption.
Journal: The Journal of experimental medicine
Published: January 16, 2023
Establishing 20S Proteasome Genetic, Translational and Post-Translational Status from Precious Biological and Patient Samples with Top-Down MS.
Journal: Cells
Published: December 05, 2022
Last Updated: 09/26/2026